Drugs / Oracure
last change Jul 2024 re-read 2 minutes ago

Oracure

Developed for
mouth disorder · mucositis
Investigated by
Hams Hamed Abdelrahman

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04308161 Nov 2019 → Oct 2020 mouth disorder Hams Hamed Abdelrahman Unknown No outcome recorded
Also used as a comparator or background therapy in 4 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT04317183 Background May 2019 → Mar 2020 chemotherapy-induced oral mucositis Hams Hamed Abdelrahman Unknown No outcome recorded
Phase 2 NCT03833570 Background Jan → Nov 2018 mucositis Hams Hamed Abdelrahman Completed No outcome recorded
Phase not applicable2 trials
NCT06117904 Background Jan → Jun 2024 mucositis Beni-Suef University Completed No outcome recorded
NCT05181943 Comparator Oct 2020 → Nov 2021 mucositis Alexandria University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as oracure “These therapies included anti-fungal agents (Miconaz oral gel), topical anesthetics and anti-inflammatory drugs (BBC oral spray), topical analgesic gel (Oracure gel), sodium...” NCT06117904
4

“Conventional treatment using oracure, BBC spray, miconaz three times daily” NCT05181943

NCT04308161

NCT03833570

NCT04317183

Route Topical Topical analgesic gel” NCT03833570